In recent years, the emergence of more and more chemotherapy regimens and immune drugs has made patients with advanced liver cancer have more treatment options, resulting in an increase in survival rates.
Hepatic artery perfusion chemotherapy (HAIC) combined with immunotherapy is a method based on immunotherapy, while increasing the local perfusion concentration of chemotherapy drugs for target lesions through hepatic artery perfusion chemotherapy, which can create radical resection opportunities for more patients with liver cancer and bring more lasting survival benefits. So, which liver cancer patients are suitable for chemotherapy + immunotherapy regimens? How do patients choose the right treatment?
In order to help everyone understand liver cancer and understand liver cancer, Shanghai Poster Group Maritime Famous Doctors specially invited domestic experts in the field of liver cancer to open the "Liver Cancer Famous Doctors Online" series. The expert in this issue is Wang Ping, Department of Interventional Medicine, Affiliated Cancer Hospital of Harbin Medical University, who brought the video live broadcast of "Liver Cancer Famous Doctor Online" series - chemotherapy and immunotherapy to solve the survival dilemma of liver cancer.
Live streaming time
Sunday, November 28, 2021 10:30 - 11:30
Watch the full video
Enter today's headline "Famous Doctors on the Sea" account, watch the experts' online videos, face to face with famous doctors, and obtain authoritative and credible popular science knowledge.